| Literature DB >> 27163462 |
Matteo Salgarello1, Gianluigi Lunardi, Alessandro Inno, Stefano Pasetto, Fabrizia Severi, Giancarlo Gorgoni, Stefania Gori.
Abstract
F-NaF is a radiopharmaceutical widely used in PET imaging to detect bone metastases. Several cases of F-NaF uptake from brain metastases have been described, but a specific protocol for the evaluation of brain metastases with F-NaF has not been developed yet. Here we report images of F-NaF PET/CT, standard CT, and MRI of a brain metastasis in a patient with non-small lung cancer. Through a dynamic acquisition procedure, we have identified the first minutes after injection as the preferable time point of imaging acquisition for the study of brain metastases with F-NaF.Entities:
Mesh：
Substances：
Year: 2016 PMID： 27163462 DOI： 10.1097/RLU.0000000000001186
Source DB: PubMed Journal: Clin Nucl Med ISSN： 0363-9762 Impact factor: 7.794